U.S. Clinical Trials Market size is expected to reach USD 32.4 billion by 2028
U.S. Clinical Trials Industry Overview The U.S. clinical trials market size was valued at USD 21.4 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.3% from 2021 to 2028. The market is majorly driven by a rise in R&D activities, increasing vaccine trials, the need for personalized medicine, and the increasing use of new technologies. The associations of pharmaceutical companies with clinical research organizations and biotechnological companies are also expected to drive market growth. The COVID-19 pandemic has placed a huge strain on the market. The order of home quarantine or stay-at-home is followed everywhere and the industry is no exception to it. The pandemic has affected the ability of trials to be done safely and effectively. Gather more insights about the market drivers, restrains and growth of the U.S. Clinical Trials Market It has halted new study initiatives for other diseases and redirected the reso...